Published date: Sep 15 2022

Journal Title: KnE Medicine

Issue title: The International Conference of Medicine and Health (ICMEDH)

Pages: 428–436

DOI: 10.18502/kme.v2i3.11894

Kiageng Nico PNtanyakiagengnico@gmail.comMuhammadiyah University General Hospital of Malang

Agung RudiardiHospital Management Faculty of Medicine, University of Brawijaya Malang

Rezky Ami CahyaharnitaMuhammadiyah University General Hospital of Malang

Djoni DjunaediMuhammadiyah University General Hospital of Malang

The global death rate from COVID-19 is 2.1%, while it is 3.2% in Indonesia. There were 81 deaths (32%) out of the 244 total COVID-19 cases at Muhammadiyah University General Hospital of Malang in July 2021. This study examined the immediate causes and conditions leading to these deaths in COVID-19 patients. We aimed to describe several causes of death defined in the death certificate compared with the autopsy findings based on previous literature. This was a retrospective and analytical observational study. There was a death rate of 40.7% in the emergency department, 22.0% in the intensive care unit and 37.0% outside of the intensive care unit. Respiratory failure was the main immediate cause of death with 77 cases (95.06%). Covid-19 pneumonia was the main condition leading to death with 61 cases (75.31%). These data are expected to encourage clinicians to better understand and perceive the circumstances under which a patient may progress from severe infection towards death and manage such cases more efficiently.

Keywords: causes of death, COVID-19, immediate condition leading to causes of death, emergency room, non-ICU, ICU

[1] Garima S, Singh N. Fatality in COVID 19: An overview of causes of death and organ involvement. International Journal of Advances in Medicine. 2020;7(7):1190.


[2] Elezkurtaj S, Greuel S, Ihlow J, Michaelis EG, Bischoff P, Kunze CA, et al. Causes of death and comorbidities in hospitalized patients with COVID-19. Scientific Reports. 2021;11(1):1–9.


[3] Surendra H, Elyazar IR, Djaafara BA, Ekawati LL, Saraswati K, Adrian V, et al. Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: A hospital-based retrospective cohort study. The Lancet Regional Health - Western Pacific. 2021;9:100108.


[4] Nguyen NT, Chinn J, de Ferrante M, Kirby KA, Hohmann SF, Amin A. Male gender is a predictor of higher mortality in hospitalized adults with COVID-19. PLoS ONE. 2021;16(7 July):1–6.


[5] Peckham H, de Gruijter NM, Raine C, Radziszewska A, Ciurtin C, Wedderburn LR, et al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nature Communications. 2020;11(1):1–10.


[6] Ho FK, Petermann-Rocha F, Gray SR, Jani BD, Vittal Katikireddi S, Niedzwiedz CL, et al. Is older age associated with COVID-19 mortality in the absence of other risk factors? General population cohort study of 470,034 participants. PLoS ONE. 2020;15(11 November):1–11.


[7] Elezkurtaj S, Greuel S, Ihlow J, Michaelis E, Bischoff P, Kunze CA, et al. Causes of Death and Comorbidities in Patients with COVID-19. Scientific Reports. 2020.


[8] Trougakos IP, Stamatelopoulos K, Terpos E, Tsitsilonis OE, Aivalioti E, Paraskevis. D, et al. Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications. Journal of Biomedical Science. 2021;28(1):1–18.


[9] Bhattacharyya R, Iyer P, Phua GC, Lee JH. The interplay between coagulation and inflammation pathways in COVID-19-associated respiratory failure: A narrative review. Pulmonary Therapy. 2020;6(2):215–31.


[10] Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular disease, drug therapy, and mortality in Covid-19. New England Journal of Medicine. 2020;382(25):102.


[11] Wichmann D, Sperhake JP, Lütgehetmann M, Steurer S, Edler C, Heinemann A, et al. Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study. Annals of internal medicine. 2020;173(4):268–77.


[12] Vincent JL, Taccone FS. Understanding pathways to death in patients with COVID-19. The Lancet Respiratory Medicine. 2020;8(5):430–2.


[13] Du RH, Liang LR, Yang CQ, Wang W, Cao TZ, Li M, et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARSCoV- 2: A prospective cohort study. European Respiratory Journal. 2020;55(5).


[14] Nasucha M, Moenawar MG. Covid-19, Asimetri Dan Keterbukaan Informasi Publik. Media, Komunikasi, dan Informasi di Masa Pandemi COvid-19. 2020;74–93.


[15] Hajjar LA, Costa IBS da S, Rizk SI, Biselli B, Gomes BR, Bittar CS, et al. Intensive care management of patients with COVID-19: A practical approach. Annals of Intensive. Care. 2021;11(1).


[16] Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al. Acute respiratory distress syndrome: The Berlin definition. JAMA - Journal of the. American Medical Association. 2012;307(23):2526–33.